Oncology billing and coding refers to the process of assigning the appropriate medical codes to the procedures and services provided to cancer patients, and submitting claims for reimbursement to insurance companies or government programs such as Medicare and Medicaid.
Oncology in-house billing refers to the process of billing and collecting payment for oncology services provided by a healthcare facility within the facility itself, rather than outsourcing the billing process to a third-party billing company.
Chemotherapy administration codes apply to parenteral administration of non-radionuclide anti-neoplastic drugs
Chemotherapy administration codes apply to the parenteral administration of non-radionuclide anti-neoplastic drugs, anti-neoplastic agents, or substances such as monoclonal antibody agents, and other biologic response modifiers.
Many of the guidelines updated for 2022 focus on the need to code the diagnosis to the highest level of specificity.